Abstract
Abdominal aortic aneurysm (AAA) is a common aortic disease with a progressive nature. There is no approved pharmacological treatment that would effectively slow the growth of the aneurysm or prevent rupture. Necrosis is a form of programmed necrosis that is regulated by receptor-interacting protein kinases (RIPs). We have recently shown that a lack of RIP3 in mice prevented aneurysm formation.
The aim of this study is to test whether disruptive necrosis affects the progression of existing aneurysms using RIP1 inhibitors Necrostatin-1 (Nec-1) and optimized forms of Nec-1, 7-Cl-O-Nec-1 (Nec-1 s). Seven days after induction of the aneurysm by elastase perfusion, mice were randomly administered DMSO, Nec-1 (3.2 mg / kg / day) and Nec-1s (1.6 mg / kg / day) by intraperitoneal injection. After sacrifice on day 14 of postaneurysm induction, the aortic expansion in the Nec-1s group (64.12 ± 4.80%) was significantly smaller than in the DMSO group (172.80 ± 13.68%) (P <0.05).
Product Details:
Alternate Name | 5-((7-Cl-1H-indol-3-yl)methyl)-3-methylimidazolidine-2,4-dione); 7-Cl-O-Nec-1 |
---|
Peptide Sequence | No |
---|
Appearance | Yellow solid |
---|
CAS # | 852391-15-2 |
---|
Molecular Formula | C₁₃H₁₂ClN₃O₂ |
---|
Molecular Weight | 277.71 |
---|
Purity | ≥96% by TLC and LC-MS |
---|
Solubility | DMSO |
---|
SMILES | CN1C(=O)C(NC1=O)CC2=CNC3=C2C=CC=C3Cl |
---|
InChi | InChI=1S/C13H12ClN3O2/c1-17-12(18)10(16-13(17)19)5-7-6-15-11-8(7)3-2-4-9(11)14/h2-4,6,10,15H,5H2,1H3,(H,16,19) |
---|
InChi Key | WIKGAEMMNQTUGL-UHFFFAOYSA-N |
---|
PubChem CID | 643953 |
---|
Handling | Protect from light and moisture |
---|
Storage Conditions | -20°C |
---|
Shipping Conditions | Gel Pack |
---|
USAGE | For Research Use Only! Not For Use in Humans. |
---|

biovision nec 1s
Descriptions:
A potent necroptosis inhibitor. Displays higher activity in inhibiting necroptosis in Jurkat cells than Nec-1 (Cat. No. 1864) (EC₅₀ = 210 nM versus EC₅₀ = 490 nM), as well as showing no nonspecific cytotoxicity at high concentrations (~100 mM). More useful for in-cell and in vivo experiments compared to Nec-1.
The mean aortic diameter of Nec-1-treated mice appeared to be smaller (121.60 ± 10.40%) than the DMSO group, although the difference was not statistically significant (P = 0.1). Histologically, the aortic structure of Nec-1s-treated mice appeared normal, with continuous and organized elastin layers and rich SMCs expressing αActin. In addition, Nect-1 treatment reduced macrophage infiltration and MMP9 accumulation and increased tropoelastin and lysyl oxidase aortic levels. Together, our data suggest that pharmacological inhibition of necrosis by Nec-1 stabilizes pre-existing aneurysms by reducing inflammation and promoting connective tissue repair.
(1S)-(-)-α-Pinene |
C7097-100 | ApexBio | 100mg | EUR 40 |
|
(1S)-(-)-α-Pinene |
C7097-200 | ApexBio | 200mg | EUR 50 |
|
(1S)-(-)-alpha-Pinene |
TBW01089 | ChemNorm | 0.1mL | Ask for price |
(1S,3R)-3-aminocyclohexanol |
20-abx184839 | Abbexa | | |
|
(1S,3S)-3-Aminocyclohexanol |
20-abx184840 | Abbexa | | |
|
Milnacipran ((1S-cis) hydrochloride) |
HY-B0168B | MedChemExpress | 5mg | EUR 224.4 |
NPEC-caged-(1S,3R)-ACPD |
B7369-10 | ApexBio | 10 mg | EUR 661.2 |
NPEC-caged-(1S,3R)-ACPD |
B7369-50 | ApexBio | 50 mg | EUR 2590.8 |
(1S,3R,5R)-PIM447 (dihydrochloride) |
HY-19322C | MedChemExpress | 50mg | EUR 2539.2 |
cis-(1S,2R)-2-Aminocyclopentanol hydrochloride |
20-abx182399 | Abbexa | - EUR 594.00
- EUR 3951.60
- EUR 1395.60
| |
|
Microtubule Associated Protein 1S (MAP1S) Antibody |
abx234975-100ug | Abbexa | 100 ug | EUR 661.2 |
|
Tert-Butyl (1S,3R)-3-Hydroxycyclopentylcarbamate |
20-abx185572 | Abbexa | - EUR 678.00
- EUR 393.60
- EUR 1612.80
| |
|
(1S,3S)-Methyl 3-aminocyclopentanecarboxylate hydrochloride |
abx186027-1g | Abbexa | 1 g | EUR 3316.8 |
|
Microtubule Associated Protein 1S (MAP1S) Antibody |
20-abx109998 | Abbexa | - EUR 493.20
- EUR 2214.00
- EUR 718.80
- EUR 218.40
- EUR 360.00
| - 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
(1S,2R)-2-(Boc-amino)cyclopentanecarboxylicacid |
20-abx180085 | Abbexa | - EUR 427.20
- EUR 2380.80
- EUR 927.60
| |
|
Microtubule-associated protein 1S Polyclonal Antibody |
42570-100ul | SAB | 100ul | EUR 399.6 |
Microtubule Associated Protein 1S (MAP1S) Antibody |
20-abx113745 | Abbexa | | |
|
Microtubule Associated Protein 1S (MAP1S) Antibody |
abx032611-400ul | Abbexa | 400 ul | EUR 627.6 |
|
Microtubule Associated Protein 1S (MAP1S) Antibody |
abx032611-80l | Abbexa | 80 µl | EUR 343.2 |
|
Microtubule Associated Protein 1S (MAP1S) Antibody |
20-abx002312 | Abbexa | | |
|
Human Microtubule-associated protein 1S (MAP1S) |
1-CSB-RP135494h | Cusabio | - EUR 456.00
- EUR 256.80
- EUR 1570.80
- EUR 672.00
- EUR 1047.60
- EUR 314.40
| - 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Microtubule-associated protein 1S(MAP1S),partial expressed in E.coli |
Microtubule Associated Protein 1S (MAP1S) Antibody |
abx145490-100ug | Abbexa | 100 ug | EUR 469.2 |
|
Recombinant Microtubule Associated Protein 1S (MAP1S) |
RPU58260-100ug | Biomatik Corporation | 100ug | EUR 537.6 |
Recombinant Microtubule Associated Protein 1S (MAP1S) |
RPU58260-1mg | Biomatik Corporation | 1mg | EUR 2496 |
Recombinant Microtubule Associated Protein 1S (MAP1S) |
RPU58260-50ug | Biomatik Corporation | 50ug | EUR 418 |
(1S,2S)-(+)-N-p-Tosyl-1,2-diphenylethylenediamine |
20-abx184505 | Abbexa | | |
|
(1S,2S)-2-Phenylcyclopropane-1-carboxylic acid |
abx184838-1g | Abbexa | 1 g | EUR 1762.8 |
|
Microtubule Associated Protein 1S (MAP1S) Antibody (FITC) |
20-abx107080 | Abbexa | - EUR 493.20
- EUR 2214.00
- EUR 718.80
- EUR 218.40
- EUR 360.00
| - 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Microtubule Associated Protein 1S (MAP1S) Antibody (Biotin) |
20-abx105663 | Abbexa | - EUR 493.20
- EUR 2214.00
- EUR 718.80
- EUR 218.40
- EUR 360.00
| - 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Microtubule Associated Protein 1S (MAP1S) Antibody Pair |
abx117556-1pair5x96wellplates | Abbexa | 1 pair (5x96 well plates) | EUR 1212 |
|
Microtubule-associated protein 1S Polyclonal Conjugated Antibody |
C42570 | SAB | 100ul | EUR 476.4 |
GFP/Firefly Luciferase MM.1S Cell Line |
78376 | BPS Bioscience | 2 vials | EUR 2280 |
Description: Recombinant stable MM.1S cell line constitutively expressing a firefly luciferase and enhanced GFP (eGFP) cassette driven by a CMV promoter. |
Microtubule Associated Protein 1S (MAP1S) Antibody (HRP) |
20-abx108501 | Abbexa | - EUR 493.20
- EUR 2214.00
- EUR 718.80
- EUR 218.40
- EUR 360.00
| - 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Human Complement Component 1s (C1s) ELISA Kit |
IHUC1SKT | Innovative research | each | EUR 702 |
|
Description: Human Complement Component 1s (C1s) ELISA Kit |
(1S,4S)-2-Boc-2,5-diazabicyclo[2.2.1]heptane |
20-abx181395 | Abbexa | - EUR 678.00
- EUR 292.80
- EUR 477.60
| |
|
(1S,2S)-N,N\'-Bismethyl-1,2-cyclohexane-diamine |
20-abx185675 | Abbexa | - EUR 477.60
- EUR 243.60
- EUR 727.20
- EUR 360.00
| |
|